These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3514011)

  • 1. Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.
    Brandely M; Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1986 Jan; 63(1):118-26. PubMed ID: 3514011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains.
    Pelletier M; Forget A; Bourassa D; Gros P; Skamene E
    J Immunol; 1982 Nov; 129(5):2179-85. PubMed ID: 6749986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
    Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R
    Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to the cell wall of Mycobacterium bovis BCG.
    Orme IM
    Clin Exp Immunol; 1988 Mar; 71(3):388-93. PubMed ID: 3289800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice.
    Wing EJ
    Immunology; 1981 Nov; 44(3):509-15. PubMed ID: 7319550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
    Appelberg R; Sarmento AM
    Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG.
    Forget A; Skamene E; Gros P; Miailhe AC; Turcotte R
    Infect Immun; 1981 Apr; 32(1):42-7. PubMed ID: 7012036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of T-2 toxin on murine host resistance to three facultative intracellular bacterial pathogens: Listeria monocytogenes, Salmonella typhimurium, and Mycobacterium bovis.
    Ziprin RL; McMurray DN
    Am J Vet Res; 1988 Jul; 49(7):1188-92. PubMed ID: 3138932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice.
    Jeevan A; Kripke ML
    J Immunol; 1989 Nov; 143(9):2837-43. PubMed ID: 2681417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary BCG cell wall vaccination in mice.
    Reuman PD; Ayoub EM
    Microbios; 1987; 49(198):7-15. PubMed ID: 3550393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of non-specific resistance to infection with Listeria monocytogenes.
    Wirsing von König CH; Heymer B; Finger H; Emmerling P; Hof H
    Infection; 1988; 16 Suppl 2():S112-7. PubMed ID: 3138182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal.
    Orme IM; Collins FM
    Clin Exp Immunol; 1984 Apr; 56(1):81-8. PubMed ID: 6424988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. I. Suppression of delayed-type hypersensitivity].
    Nakamura RM; Goto Y; Kinomoto M
    Kekkaku; 1990 Sep; 65(9):581-4. PubMed ID: 2232436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
    Gros P; Skamene E; Forget A
    J Immunol; 1983 Oct; 131(4):1966-72. PubMed ID: 6311901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
    Lagrange PH
    Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
    [No Abstract]   [Full Text] [Related]  

  • 20. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.